> Lundbeck terminated development of Lu AF35700 in the wake of the failure of the drug in patients with schizophrenia. Release
> Analysts at Jefferies raised their price target for Genmab after reviewing the prospects of its pipeline programs. Genmab reported first-half results this week. Statement
> The Dementia Discovery Fund invested £6.5 million ($7.9 million) in AstronauTx, a startup that aims to treat Alzheimer’s disease by targeting astrocytes. Release
> AC Immune entered into a neurodegenerative disease research collaboration with the University of Pennsylvania. Statement
> Scotland’s Synpromics accepted a takeover offer from AskBio. Release